These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 990463)

  • 41. Immune response to sheep red cells in AKR mouse leukemia.
    Ram MD; Kohn RR; Novak D
    Am J Pathol; 1973 Jul; 72(1):39-52. PubMed ID: 4719527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Postradiation life span of mice in relation to the modifying action of leukemic cells administered].
    Svirnovskiĭ AI; Bakun AV; Shimanskaia TV
    Radiobiologiia; 1988; 28(3):412-5. PubMed ID: 3041440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Detection of erythroblast antigen in mice in tumor cells and in leukemia by means of immunofluorescence and immunoautoradiography].
    Ievleva ES; Rozinova EN; Irlin IS
    Probl Gematol Pereliv Krovi; 1979 Nov; 24(11):40-3. PubMed ID: 388410
    [No Abstract]   [Full Text] [Related]  

  • 44. [A peculiarity in the humoral immunity of BALB/C mice with Rauscher leukemia].
    Sokolov PP; Bergol'ts VM
    Biull Eksp Biol Med; 1976 Mar; 81(3):356-8. PubMed ID: 1085178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of Rauscher leukaemia virus on the immune system in susceptible and resistant mouse strains.
    Tóth FD; Karsai T; Váczi L
    Acta Microbiol Acad Sci Hung; 1971; 18(4):271-8. PubMed ID: 4136204
    [No Abstract]   [Full Text] [Related]  

  • 46. Mechanism of nonresponsiveness to AKR/Gross leukemia virus in AKR.H-2b:Fv-1b mice. An analysis of precursor cytotoxic T lymphocyte frequencies in young versus moderately aged mice.
    Wegmann KW; McMaster JS; Green WR
    J Immunol; 1991 Apr; 146(7):2469-77. PubMed ID: 2005406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antilymphocytic humoral autoimmune response of mice with developing Rauscher leukemia directed against group-specific retrovirus antigens].
    Ter-Grigorov VS; Graf IA; Pivnik AV; Etkin AF; Moskovkina OIa
    Eksp Onkol; 1987; 9(6):48-51. PubMed ID: 3325268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Kinetic patterns of the development of transplantable AKR leukemia].
    Dronova LM; Erokhin VN; Belich EI
    Vopr Onkol; 1978; 24(9):65-71. PubMed ID: 706297
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo or in vitro treatments with anti-I-J alloantisera abolish immunity to AKR leukemia.
    Meruelo D; Flieger N; Smith D; McDevitt HO
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2178-82. PubMed ID: 6769122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Development of spontaneous leukemia in mice of the highly leukemic AKR line on exposure to 3-indolylacrylic acid].
    Sergeeva TI; Zharova EI
    Probl Gematol Pereliv Krovi; 1979 Nov; 24(11):44-5. PubMed ID: 583072
    [No Abstract]   [Full Text] [Related]  

  • 51. Identification and characterization of a soluble suppressor factor(s) in the serum of AKR mice bearing lymphocytic leukemia.
    Simon JD; Freed BM; Davignon D; Albala MM
    Cell Immunol; 1983 Nov; 82(1):163-73. PubMed ID: 6605807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Change in the content of free radicals in the liver as an indication of the development of experimental leukoses].
    Khristianovich DS; Dronova LM; Varfolomeev VN; Bogdanov GN; Emanuel' NM
    Dokl Akad Nauk SSSR; 1977; 236(4):1011-4. PubMed ID: 923423
    [No Abstract]   [Full Text] [Related]  

  • 53. [Structural and functional properties of the target tissue in mice predisposed and resistant to the development of leukemia].
    Svirnovskiĭ AI; Levin VI; Shimanskaia TV; Bakun AV; Nikolaĭchik VV
    Patol Fiziol Eksp Ter; 1979; (1):58-61. PubMed ID: 424246
    [No Abstract]   [Full Text] [Related]  

  • 54. Leukemia in AKR mice. II. Two modes of suppression of in vitro antibody formation by leukemic cells.
    Roman JM; Golub ES
    Cell Immunol; 1978 Oct; 40(2):316-25. PubMed ID: 719762
    [No Abstract]   [Full Text] [Related]  

  • 55. [Relationship between the life span of tumor-bearing animals and the kinetics of development of the malignant process in mice with transplanted leukemia La].
    Gor'kov VA; Ostrovskaia LA
    Izv Akad Nauk SSSR Biol; 1977; (3):444-7. PubMed ID: 886072
    [No Abstract]   [Full Text] [Related]  

  • 56. Quantitation of the immune rejection of allotransplanted AKR leukemic cells.
    Ducos R; Valeriote F
    Transplantation; 1976 Apr; 21(4):279-81. PubMed ID: 941216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum-mediated leukemia cell destruction in AKR mice.
    Kassel RL; Old LJ; Carswell EA; Fiore NC; Hardy WD
    J Exp Med; 1973 Oct; 138(4):925-38. PubMed ID: 4744012
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation of complement by spontaneous leukemic cells of AKR mice.
    Okada N; Okada H
    Int J Cancer; 1978 Sep; 22(3):282-7. PubMed ID: 308935
    [No Abstract]   [Full Text] [Related]  

  • 59. Mammalian oncornaviruses: an introductory review.
    Hilgers J
    Acta Microbiol Acad Sci Hung; 1979; 26(2):149-52. PubMed ID: 231895
    [No Abstract]   [Full Text] [Related]  

  • 60. Long-term carcinogenicity of cyclophosphamide in two mouse strains with different spontaneous leukemia incidence.
    Petru E; Berger MR; Schmähl D
    Cancer Lett; 1989 Mar; 44(3):221-6. PubMed ID: 2924289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.